{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:31:23Z","timestamp":1785259883343,"version":"3.55.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive neoplasm derived from plasmacytoid dendritic cells (pDCs). In this study, we investigated by immunohistochemical analysis the expression of E-cadherin (EC) on pDCs in reactive lymph nodes and tonsils, bone marrow, and in BPDCN. We compared the expression of EC in BPDCN to that in leukemia cutis (LC) and cutaneous lupus erythematosus (CLE), the latter typically featuring pDC activation. In BPDCN, we also assessed the immunomodulatory activity of malignant pDCs through the expression of several type I interferon (IFN-I) signaling effectors and downstream targets, PD-L1\/CD274, and determined the extent of tumor infiltration by CD8-expressing T cells. In reactive lymph nodes and tonsils, pDCs expressed EC, whereas no reactivity was observed in bone marrow pDCs. BPDCN showed EC expression in the malignant pDCs in the vast majority of cutaneous (31\/33 cases, 94%), nodal, and spleen localizations (3\/3 cases, 100%), whereas it was more variable in the bone marrow (5\/13, 38,5%), where tumor cells expressed EC similarly to the skin counterpart in 4 cases and differently in other 4. Notably, EC was undetectable in LC (n=30) and in juxta-epidermal pDCs in CLE (n=31). Contrary to CLE showing robust expression of IFN-I-induced proteins MX1 and ISG5 in 20\/23 cases (87%), and STAT1 phosphorylation, BPDCN biopsies showed inconsistent levels of these proteins in most cases (85%). Expression of IFN-I-induced genes, <jats:italic toggle=\"yes\">IFI27<\/jats:italic>, <jats:italic toggle=\"yes\">IFIT1<\/jats:italic>, <jats:italic toggle=\"yes\">ISG15<\/jats:italic>, <jats:italic toggle=\"yes\">RSAD2<\/jats:italic>, and <jats:italic toggle=\"yes\">SIGLEC1<\/jats:italic>, was also significantly (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05) lower in BPDCN as compared with CLE. In BPDCN, a significantly blunted IFN-I response correlated with a poor CD8<jats:sup>+<\/jats:sup>T-cell infiltration and the lack of PD-L1\/CD274 expression by the tumor cells. This study identifies EC as a novel pDC marker of diagnostic relevance in BPDCN. The results propose a scenario whereby malignant pDCs through EC-driven signaling promote the blunting of IFN-I signaling and, thereby, the establishment of a poorly immunogenic tumor microenvironment.<\/jats:p>","DOI":"10.1097\/pas.0000000000001747","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T20:34:46Z","timestamp":1622752486000},"page":"1428-1438","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm"],"prefix":"10.1097","volume":"45","author":[{"given":"Luisa","family":"Lorenzi","sequence":"first","affiliation":[{"name":"Department of Molecular and Translational Medicine, Section of Pathology"},{"name":"Pathology Unit, ASST Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lonardi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Section of Pathology"},{"name":"Pathology Unit, ASST Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Vairo","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, A. Nocivelli Institute of Molecular Medicine, University of Brescia and Section of Medical Genetics, Spedali Civili"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernardelli","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Section of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tomaselli","sequence":"additional","affiliation":[{"name":"Pathology Unit, ASST Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Bugatti","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Section of Pathology"},{"name":"Pathology Unit, ASST Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Licini","sequence":"additional","affiliation":[{"name":"Pathology Unit, ASST Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Arisi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Section of Dermatology, University of Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cerroni","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[{"name":"Haematology Unit, ASST Spedali Civili di Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vermi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Section of Pathology"},{"name":"Pathology Unit, ASST Spedali Civili di Brescia"},{"name":"Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Clara","family":"Giliani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, A. Nocivelli Institute of Molecular Medicine, University of Brescia and Section of Medical Genetics, Spedali Civili"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchetti","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Section of Pathology"},{"name":"Pathology Unit, ASST Spedali Civili di Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.hoc.2020.01.002","article-title":"Molecular features of blastic plasmacytoid dendritic cell neoplasm: DNA mutations and epigenetics","volume":"34","author":"Sapienza","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/10428194.2020.1845338","article-title":"Mutational analysis in different foci revealing the clonal evolution of blastic plasmacytoid dendritic cell neoplasm","volume":"62","author":"Zhang","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/bloodadvances.2020001875","article-title":"Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant","volume":"4","author":"Yun","year":"2020","journal-title":"Blood Adv"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/bloodadvances.2020002474","article-title":"Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients","volume":"4","author":"Laribi","year":"2020","journal-title":"Blood Adv"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3324\/haematol.2018.202093","article-title":"Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target","volume":"104","author":"Sapienza","year":"2019","journal-title":"Haematologica"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood-2015-09-671040","article-title":"Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms","volume":"127","author":"Emadali","year":"2016","journal-title":"Blood"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1182\/bloodadvances.2019000173","article-title":"Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm","volume":"4","author":"Pemmaraju","year":"2020","journal-title":"Blood Adv"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/PAS.0000000000000590","article-title":"Expression of programmed cell death 1 ligands (PD-L1 and PD-L2) in histiocytic and dendritic cell disorders","volume":"40","author":"Xu","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.18632\/oncotarget.4378","article-title":"Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1","volume":"6","author":"Gatalica","year":"2015","journal-title":"Oncotarget"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1066896920938130","article-title":"E-cadherin expression in blastic plasmacytoid dendritic cell neoplasms: an unrecognized finding and potential diagnostic pitfall","volume":"29","author":"Shenjere","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI121421","article-title":"E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs","volume":"128","author":"Bi","year":"2018","journal-title":"J Clin Invest"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.it.2011.03.004","article-title":"E-cadherin: gatekeeper of airway mucosa and allergic sensitization","volume":"32","author":"Nawijn","year":"2011","journal-title":"Trends Immunol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1182\/blood-2011-10-384289","article-title":"Regulation and function of the E-cadherin\/catenin complex in cells of the monocyte-macrophage lineage and DCs","volume":"119","author":"Van den Bossche","year":"2012","journal-title":"Blood"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V96.13.4276","article-title":"Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation","volume":"96","author":"Riedl","year":"2000","journal-title":"Blood"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/79747","article-title":"Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization","volume":"1","author":"Cella","year":"2000","journal-title":"Nat Immunol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00428-003-0918-8","article-title":"The plasmacytoid monocyte\/interferon producing cells","volume":"443","author":"Facchetti","year":"2003","journal-title":"Virchows Arch"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.imbio.2009.06.013","article-title":"Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage","volume":"214","author":"Vermi","year":"2009","journal-title":"Immunobiology"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.2007.08137.x","article-title":"The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets","volume":"157","author":"Wenzel","year":"2007","journal-title":"Br J Dermatol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ygeno.2014.06.003","article-title":"Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease","volume":"104","author":"Dey-Rao","year":"2014","journal-title":"Genomics"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"e000328","DOI":"10.1136\/lupus-2019-000328","article-title":"Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature","volume":"6","author":"Shalbaf","year":"2019","journal-title":"Lupus Sci Med"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-0625.2007.00556.x","article-title":"Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches","volume":"16","author":"Wenzel","year":"2007","journal-title":"Exp Dermatol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1365-2133.2005.06784.x","article-title":"Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br J Dermatol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jid.2020.05.077","article-title":"Rethinking the pathogenesis of cutaneous lupus","volume":"141","author":"Kahlenberg","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3389\/fimmu.2018.02129","article-title":"Interferon-alpha up-regulates the expression of PD-L1 molecules on immune cells through STAT3 and p38 signaling","volume":"9","author":"Bazhin","year":"2018","journal-title":"Front Immunol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni1213","article-title":"A critical function for type I interferons in cancer immunoediting","volume":"6","author":"Dunn","year":"2005","journal-title":"Nat Immunol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u201cImmunoscore\u201d in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/annonc\/mdv560","article-title":"Strategies for clinical implementation of TNM-immunoscore in resected nonsmall-cell lung cancer","volume":"27","author":"Donnem","year":"2016","journal-title":"Ann Oncol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/modpathol.2017.156","article-title":"Implications of the tumor immune microenvironment for staging and therapeutics","volume":"31","author":"Taube","year":"2018","journal-title":"Mod Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s13402-020-00496-7","article-title":"Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms","volume":"43","author":"Blessin","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1084\/jem.20160600","article-title":"Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells","volume":"213","author":"Wu","year":"2016","journal-title":"J Exp Med"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ni.2467","article-title":"Re(de)fining the dendritic cell lineage","volume":"13","author":"Satpathy","year":"2012","journal-title":"Nat Immunol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","article-title":"Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development","volume":"135","author":"Cisse","year":"2008","journal-title":"Cell"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.2020007274","article-title":"CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia","volume":"136","author":"Wang","year":"2020","journal-title":"Blood"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1002\/ajh.24956","article-title":"A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis","volume":"93","author":"Minetto","year":"2018","journal-title":"Am J Hematol"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/AJCP8M4QQTAZPGRP","article-title":"E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms","volume":"141","author":"Ohgami","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2007.08.015","article-title":"Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation","volume":"27","author":"Jiang","year":"2007","journal-title":"Immunity"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1532\/IJH97.04116","article-title":"A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma","volume":"81","author":"Maeda","year":"2005","journal-title":"Int J Hematol"},{"key":"R49-20250608","first-page":"91","article-title":"Derivation of leukemic plasmacytoid dendritic cells coexpressing a progenitor cell surface antigen, CD117, without interferon-alpha production","volume":"25","author":"Takeda","year":"2007","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.leukres.2009.03.047","article-title":"A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naive T cells","volume":"33","author":"Narita","year":"2009","journal-title":"Leuk Res"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2004-06-2416","article-title":"Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells","volume":"105","author":"Garnache-Ottou","year":"2005","journal-title":"Blood"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/DAD.0b013e31824d689c","article-title":"Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies","volume":"34","author":"Petrella","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/eji.200324531","article-title":"Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts","volume":"34","author":"Chaperot","year":"2004","journal-title":"Eur J Immunol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","article-title":"Type I interferonopathies in pediatric rheumatology","volume":"14","author":"Volpi","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.hoc.2020.01.010","article-title":"Blastic plasmacytoid dendritic cell neoplasm: clinical presentation and diagnosis","volume":"34","author":"Deconinck","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000057631","article-title":"Immune-mediated complications during interferon therapy in hematological patients","volume":"107","author":"Raanani","year":"2002","journal-title":"Acta Haematol"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2014.64","article-title":"Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition","volume":"28","author":"Sapienza","year":"2014","journal-title":"Leukemia"},{"key":"R59-20250608","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ccell.2016.10.002","article-title":"A druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm","volume":"30","author":"Ceribelli","year":"2016","journal-title":"Cancer Cell"},{"key":"R60-20250608","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/bloodadvances.2020003359","article-title":"Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis","volume":"5","author":"Renosi","year":"2021","journal-title":"Blood Adv"},{"key":"R61-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"R62-20250608","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.immuni.2017.11.001","article-title":"High-dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization","volume":"47","author":"Alcantara-Hernandez","year":"2017","journal-title":"Immunity"},{"key":"R63-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/2326-6066.CIR-18-0141","article-title":"Collapse of the plasmacytoid dendritic cell compartment in advanced cutaneous melanomas by components of the tumor cell secretome","volume":"7","author":"Vescovi","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"R64-20250608","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"R65-20250608","doi-asserted-by":"crossref","first-page":"594609","DOI":"10.3389\/fimmu.2020.594609","article-title":"Cytokine and chemokine signals of T-cell exclusion in tumors","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:06:48Z","timestamp":1749416808000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001747","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,3]]}}}